In 2014, Gad and Huber et al. reported that the inhibition of MTH1 function by the RNAi-mediated knockdown of expression or by novel compounds (including TH588, TH287, and Crizotinib) exerted strong anti-proliferation effects in various cancer cells, but not normal cells [18,19,20]. This evidence concerns the gene NUDT1 and cancer.